Patent details

Basic Information

Publication number:

EP3542812

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP191748490

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GLYCOPEPTIDE COMPOSITIONS

French Title of Invention:

COMPOSITIONS DE GLYCOPEPTIDE

German Title of Invention:

GLYKOPEPTIDZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

06/11/2015

Grant date:

13/01/2021

EP Publication Date:

25/09/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/01/2021

EP B1 Publication Date:

13/01/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

06/11/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/10/2024

 

 

Name:

HIKMA PHARMACEUTICALS USA INC.

Address:

200 Connell Drive, 07922, Berkeley Heights, New Jersey , United States (US)

History of Owners

From:

06/01/2021

To:

22/10/2024

Name:

Xellia Pharmaceuticals ApS

Address:

Dalslandsgade 11, 2300 Copenhagen S, Denmark (DK)

Agent

Name:

VALIPAT

From:

25/01/2021

Address:

Avenue Louise 54, 1050, Bruxelles, Belgium (BE)

To:

Inventor

1

Name:

Jasprica, Ivona

Address:

Croatia (HR)

2

Name:

Keser, Sabina

Address:

Croatia (HR)

3

Name:

Pindric, Katarina

Address:

Croatia (HR)

Priority

1

Priority Number:

201462076400 P

Priority Date:

06/11/2014

Priority Country:

United States (US)

2

Priority Number:

201562168749 P

Priority Date:

30/05/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/08; A61K 38/14; A61K 47/26; A61P 31/04;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2024/13

Publication date:

05/11/2024

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

202102

Publication date:

13/01/2021

Description:

Grant (B1)

2

Issue number:

202104

Publication date:

27/01/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:

202111

Publication date:

17/03/2021

Description:

Inventor(s) changed

Deed

Power of attorney

Change Kind/ Decision Type:

Assignment

Deed Number:

RC20210000039A

Date Registered:

25/01/2021

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

VALIPAT

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20240000432A

Date Registered:

22/10/2024

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

MARKS & CLERK LLP

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

HIKMA PHARMACEUTICALS USA INC.

Address:

200 Connell Drive, 07922, Berkeley Heights, New Jersey , United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/11/2026

Annual Fee Number:

12

Annual Fee Amount:

165 Euro

Expected Payer:

Last Annual Fee Payment Date:

20/11/2025

Last Annual Fee Paid Number:

11

Last Annual Fee Paid Amount:

148 Euro

Payer:

HOFFMANN EITLE PATENT- UND RECHTSANWALTE PARTMBB

Filing date	Document type	Number of pages
25/01/2021	Request For Change	2
22/10/2024	Outgoing Correspondence	1
22/10/2024	Request For Change	20
25/01/2021	Outgoing Correspondence	2
13/03/2026	Request For Change	5
16/03/2026	Outgoing Correspondence	46